Atlanta, GA, United States of America

Leslie Gelbaum

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leslie Gelbaum. Retrieved from https://idiyas.com/inventor/leslie-gelbaum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leslie Gelbaum: Innovator in Anti-Neoplastic Compounds

Introduction

Leslie Gelbaum is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic potential. Her work focuses on creating innovative solutions to combat cancer.

Latest Patents

Leslie Gelbaum holds a patent for "Substituted N-methyl derivatives of mitindomide." This patent discloses new substituted N-methyl derivatives of mitindomide and methods of preparing the same. The novel compounds are water-soluble and exhibit anti-neoplastic activity, showcasing her commitment to advancing cancer treatment.

Career Highlights

Gelbaum's career is marked by her dedication to research and innovation in the pharmaceutical industry. She works for the United States of America as represented by the Secretary of Health and Human Services, where she continues to explore new avenues for drug development.

Collaborations

Throughout her career, Leslie has collaborated with notable colleagues, including Rudiger D Haugwitz and Venkatachala Naratanan. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Leslie Gelbaum's work in developing anti-neoplastic compounds highlights her innovative spirit and dedication to improving cancer therapies. Her contributions to the field are invaluable and continue to inspire future research in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…